참고문헌
- Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. https://doi.org/10.1161/01.CIR.97.18.1837
- Castelli WP. Epdemilology of coronary heart disease: the Framingstudy. Am J Med 1984;76:4-12. https://doi.org/10.1016/0002-9343(84)90952-5
- Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: finding form long-term follow-up of Chicago cohorts. Cardiology 1993;82:191-222. https://doi.org/10.1159/000175868
- Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000;284:311-8. https://doi.org/10.1001/jama.284.3.311
- In-Depth Analysis of the Third Korea National Health and Nutrition Examination Survey (KNHANES III). Seoul: Korea Centers for Disease Control and Prevention;2007.
- Lim S, Jang HC, Park HC, et al. Changes in metabolic syndrome of Korean children and adolescents in the period 1998 to 2001. J Endocrinol Invest 2008;31:327-33. https://doi.org/10.1007/BF03346366
- The Lipid Research Clinics Coronary Primary Prevention Trial. l. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64. https://doi.org/10.1001/jama.1984.03340270029025
- Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousidian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8. https://doi.org/10.1001/jama.1986.03380200073024
- Frick MH, Elo O, Haapak M, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middled-aged men with dyslipidemia: safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45. https://doi.org/10.1056/NEJM198711123172001
- The Lipid Research Clinics Coronary Primary Prevention Trial results. ll. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74. https://doi.org/10.1001/jama.1984.03340270043026
- Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39. https://doi.org/10.1161/01.CIR.0000133317.49796.0E
- Committee of treatment guideline for hypercholesterolemia. Treatment guideline for hypercholesterolemia. 2nd ed. Seoul: Korea Society of lipidology and atherosclerosis;2008.
- Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol 2006;110:184-90. https://doi.org/10.1016/j.ijcard.2005.07.030
- Siegel D. The gap between knowledge and practice in the treatment and prevention of cardiovascular disease. Prev Cardiol 2000;3:167-71. https://doi.org/10.1111/j.1520-037X.2000.80381.x
- Smaha LA. The American Heart Association get with the guidelines program. Am Heart J 2004;148(5 Suppl):S46-8. https://doi.org/10.1016/j.ahj.2004.09.015
- Sung J, Kim SH, Kim YD, et al. Ten centers study on the present state of treatment for hypercholesterolemia in patients with coronary artery disease. Korean J Med 2005;69:371-8.
- Kim SH, Park JS, Zo JH, Kim MA, Kim HS. Treatment gap in the management of hypercholesterolemia in Korea: return on expenditure achieved for lipid therapy (REALITY). Korean Circ J 2006;36:593-9.
- June JE. Cholesterol lowering therapy in coronary artery disease: with particular reference to statins. Korean Circ J 2001;31:849-56. https://doi.org/10.4070/kcj.2001.31.9.849
- Kim MK, Kim HL, Min HS, et al. Changes of the lipoprotein profiles with time after discontinuation of stain therapy. Korean Circ J 2008;38:36-42. https://doi.org/10.4070/kcj.2008.38.1.36
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
- Annual report on the cause of death statistics. Seoul: Korean National Statistical Office;2006.
- Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 2007;17:548-55. https://doi.org/10.1016/j.annepidem.2007.01.032
- Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008;156:112-9. https://doi.org/10.1016/j.ahj.2008.03.005
- Lee YW, Min WK, Lee W, et al. Risk analysis of coronary heart diseases in Korean adults by using the National Cholesterol Education Program Adult Treatment Panel III. J Clin Lab Anal 2007;21:178-82. https://doi.org/10.1002/jcla.20165
- Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Clin Ther 2007;29:1671-81. https://doi.org/10.1016/j.clinthera.2007.08.003
- Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14. https://doi.org/10.1161/01.ATV.11.1.2
- Schaefer EJ, Levy RI, Anderson DW, Danner RN, Brewer HB Jr, Blackwelder WC. Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet 1978;2:391-3.
- Casteli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986;112:432-7. https://doi.org/10.1016/0002-8703(86)90296-6
- Hong HS, Park JS, Ryu HK, Kim WY. The association of plasma HDLcholesterol level with cardiovascular disease related factors in Korean type 2 diabetes patients. Korean Diabetes J 2008;32:215-23. https://doi.org/10.4093/kdj.2008.32.3.215
- Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and waist-toheight ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 2009;73:1643-50. https://doi.org/10.1253/circj.CJ-09-0161
- Bersot T, Pépin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003;146:1052-9. https://doi.org/10.1016/S0002-8703(03)00516-7
- National Health Insurance Corporation. Insurance standard of dyslipidemia. Avail from: http://www.nhic.or.kr/.
피인용 문헌
- Application of New Guidelines for the Primary Prevention of Atherosclerotic Cardiovascular Disease in a Korean Population vol.22, pp.3, 2012, https://doi.org/10.5551/jat.26682